Comparative Study of Three Different Embryo Transfer Media in ICSI Cycles
Launched by SOUTH VALLEY UNIVERSITY · Jun 6, 2016
Trial Information
Current as of May 29, 2025
Unknown status
Keywords
ClinConnect Summary
Two or three embryos will be transferred at day 5 after ovum pick-up (OPU).
The patients will be divided randomly (closed envelop method) into 3 groups:
* Group A (50 patients): embryos will be transferred using a medium supplemented with 0.5 mg/mL of hyaluronic acid (EmbryoGlue®, Vitrolife, Sweden) for 20 minutes before intrauterine transfer took place
* Group B (50 patients): embryos will be transferred using a medium of 30% Protein-supplemented Culture Medium (Global total®, Life Global group, Canada) for 20 minutes.
* Group C (50 patients): a novel technique in which embryos will be t...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Age: 18-35 years
- • 2. Body mass index (BMI): ≤ 30
- • 3. Anti-mullerian hormone (AMH): 1.1 - 3
- • 4. No gynecological problem e.g. fibroid, endometriosis, uterine polyp, hydrosalpinx or adenomysis
- • 5. Male factor: mild to moderate oligo or asthenospermia
- Exclusion Criteria:
- • 1. Age: \<18 years or \>35 years
- • 2. Body mass index (BMI): \>30
- • 3. Anti-mullerian hormone (AMH): \<1.1 or \>3
- • 4. gynecological problem e.g. fibroid, endometriosis, uterine polyp, hydrosalpinx or adenomysis will be excluded
- • 5. Male factor: Abnormal sperm morphology; (globozoospermia and pin-point sperm) and azoospermia; (whether obstructive or non-obstructive) will be excluded
- • 6. Patients with recurrent implantation failure
About South Valley University
South Valley University is a reputable academic institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to fostering excellence in medical education and patient care, the university collaborates with leading healthcare professionals and researchers to conduct rigorous clinical studies aimed at improving treatment outcomes and patient safety. With a strong emphasis on ethical standards and scientific integrity, South Valley University is poised to contribute valuable insights to the medical community and enhance the overall understanding of various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials